| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-09 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |